Recombinant Antibodies Against H1N1 Influenza

Antibodies that bind with high affinity to swine H1N1 virus are described. In vivo experiments showed that one such antibody is able to fully protect mice challenged with a lethal dose of swine H1N1 virus. The antibody is also able to cure mice in a therapeutic setting when treated as late as up to 60 hours (2.5 days) after infection with swine H1N1 virus. Also described are recombinant forms of this antibody.

Patents:
WO 2,011,044,570   [MORE INFO]

Inventor(s): WRAMMERT JENS [US]; AHMED RAFI [US]; WILSON PATRICK [US]

Type of Offer: Licensing



« More Pharmaceutical Patents

---